DNLI
Price
$21.09
Change
-$0.31 (-1.45%)
Updated
Sep 11 closing price
Capitalization
3.37B
60 days until earnings call
Intraday BUY SELL Signals
FMED
Price
$31.00
Change
+$0.16 (+0.52%)
Updated
Sep 11 closing price
Net Assets
50.06M
Intraday BUY SELL Signals
Interact to see
Advertisement

DNLI vs FMED

DNLI vs FMED Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
DNLI vs. FMED commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DNLI is a StrongBuy and FMED is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
DNLI: Fundamental Ratings
DNLI
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
90
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
54
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DNLIFMED
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
81%
MACD
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
N/A
Bullish Trend 10 days ago
83%
Declines
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 3 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
78%
Aroon
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
87%
COMPARISON
Comparison
Sep 12, 2026
Stock price -- (DNLI: $21.09)
Brand notoriety:
Market capitalization --

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DNLI’s FA Score shows that 0 FA rating(s) are green while .

  • DNLI’s FA Score: 0 green, 5 red.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DNLI’s TA Score shows that 3 TA indicator(s) are bullish.

  • DNLI’s TA Score: 3 bullish, 6 bearish.

Price Growth

DNLI (@Biotechnology) experienced а -5.34% price change this weekfor the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.09%. For the same industry, the average monthly price growth was -3.45%, and the average quarterly price growth was +2531.70%.

Reported Earning Dates

DNLI is expected to report earnings on Nov 11, 2026.

Industries' Descriptions

@Biotechnology (-6.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
DNLI
Daily Signal:
Gain/Loss:
FMED
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
QMMY26.510.15
+0.58%
FT Vest Nasdaq-100 Mod Buffr ETF - May
PBAU31.960.11
+0.35%
PGIM S&P 500 Buffer 20 ETF - Aug
FEP59.560.17
+0.29%
First Trust Europe AlphaDEX® ETF
XOP195.720.25
+0.13%
SttStrtSPDRS&POil&GasExplor&ProdtnETF
SBB23.20-0.13
-0.56%
ProShares Short SmallCap600

DNLI and

Correlation & Price change

A.I.dvisor indicates that over the last year, DNLI has been loosely correlated with VIR. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if DNLI jumps, then VIR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DNLI
1D Price
Change %
DNLI100%
-1.45%
VIR - DNLI
52%
Loosely correlated
+0.38%
VCYT - DNLI
50%
Loosely correlated
-2.76%
EDIT - DNLI
49%
Loosely correlated
+1.89%
BCYC - DNLI
49%
Loosely correlated
+0.78%
PCVX - DNLI
48%
Loosely correlated
+0.97%
More

FMED and

Correlation & Price change

A.I.dvisor indicates that over the last year, FMED has been loosely correlated with NTRA. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if FMED jumps, then NTRA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FMED
1D Price
Change %
FMED100%
+0.51%
NTRA - FMED
61%
Loosely correlated
+0.86%
RGEN - FMED
56%
Loosely correlated
+0.30%
DNLI - FMED
52%
Loosely correlated
-1.45%
TXG - FMED
52%
Loosely correlated
+3.33%
PCVX - FMED
50%
Loosely correlated
+0.97%
More